![]() Buy Maxalt, rizatriptan benzoateBuy Maxalt to treat migraine headaches, with or without aura, once they have begun. The usual dosage for adults is 5 or 10 mg, taken at the onset of a migraine attack. Doses should be no less than 2 hours apart.Contraindications: Consult a doctor before taking Maxalt if you are pregnant or breastfeeding, if you are allergic to any of its ingredients, if you are taking any other medications (especially antidepressants, MAOIs, ergot-containing drugs, or any other migraine medications), or if you have a history of heart disease, blood vessel disease, high blood pressure, high cholesterol, diabetes, smoking, menopause, obesity, kidney disease, liver disease, glaucoma, or phenylketonuria. To read more about Maxalt side effects, Maxalt dosage, and for more useful information about Maxalt (rizatriptan), please click the product information link below. |
|||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||
Other name(s): Rizaliv, Rizalt |
|||||||||||||||||||||||||||||||||||||||
Often prescribed for migraines |
|||||||||||||||||||||||||||||||||||||||
Maxalt, rizatriptan benzoateChemical NamesRizatriptan Ingredients Active ingredients: rizatriptan Non-active ingredients: lactose monohydrate, microcrystalline cellulose, pregelatinized starch, ferric oxide (red), and magnesium stearate. Indications Maxalt is prescribed for the treatment of a migraine attack with or without the presence of an aura (visual disturbances, usually sensations of halos or flickering lights, which precede an attack). It cuts headaches short, but won't prevent attacks. How It Works Migraine headache symptoms are due to local cranial vasodilatation and/or to the release of vasoactive and pro-inflammatory peptides from sensory nerve endings in an activated trigeminal system. Rizatriptan’s activity against migraines can be attributed to agonist effects at 5-HT1B/1D receptors on the extra cerebral, intracranial blood vessels that become dilated during a migraine attack and on nerve terminals in the trigeminal system. Activation of these receptors results in cranial vessel constriction, inhibition of neuropeptide release and reduced transmission in trigeminal pain pathways. Dosage Oral tablets (5 mg, 10 mg) The usual dose of Maxalt and Maxalt-MLT is one 5 or 10 milligram tablet. Doses should be spaced at least 2 hours apart. Take no more than 30 milligrams a day. Maxalt should only be used by adults. Some people with risk factors for heart and blood vessel disease have suffered irregular heartbeats, heart attack or stroke after taking Maxalt, your doctor may ask you to take the first dose in the office, where you can be monitored for cardiac side effects. High blood pressure, high cholesterol, diabetes, smoking, history of heart disease in your family and menopause all increase the odds of such side effects. Use Maxalt with caution if you have liver disease or need kidney dialysis. Also alert your doctor if you have an eye condition. If you have a condition called phenylketonuria, you should be aware that the Maxalt-MLT tablets contain phenylalanine. The effects of Maxalt (Rizaliv, Rizalt, Rizatriptan Benzoate) during pregnancy have not been adequately studied. If you are pregnant or plan to become pregnant, inform your doctor immediately. Maxalt should not be used within 24 hours of treatment with another 5-HT1 agonist, or an ergotamine-containing or ergot-type medication like dihydroergotamine or methysergide. Maxalt should not be administered to patients with hemiplegic or basilar migraine. Concurrent administration of MAO inhibitors or use of rizatriptan within 2 weeks of discontinuation of MAO inhibitor therapy is contraindicated. Maxalt is contraindicated in patients who are hypersensitive to rizatriptan or any of its inactive ingredients. Maxalt should only be used where a clear diagnosis of migraine has been established. If your first dose of Maxalt has no effect on your symptoms, you may not be suffering from migraine. Ask your doctor for a re-evaluation. Serious adverse cardiac events, including acute myocardial infarction, have been reported within a few hours following the administration of rizatriptan. Life-threatening disturbances of cardiac rhythm and death have been reported within a few hours following the administration of other 5-HT1 agonists. Cases of life-threatening serotonin syndrome have been reported during combined use of selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) and triptans. Drug Interactions The following drugs may boost or add to the effect of Maxalt and should never be combined with it: MAO inhibitors (including Marplan, Nardil, and Parnate), ergot-containing drugs (including Cafergot, D.H.E. Injection and Migranal), other drugs in the Maxalt family (such as Amerge, Imitrex, and Zomig), fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine (Paxil), propranolol (Inderal), or sertraline (Zoloft). Adverse/Side Effects Side effects cannot be anticipated. If any develop or change in intensity, inform your doctor as soon as possible. More common side effects may include chest pain, dizziness, drowsiness, dry mouth, fatigue, nausea, pain, tingling skin, and weakness. Less common side effects may include clouded thinking, cold sensations, decreased sensitivity to pain, diarrhea, difficulty breathing, feeling of well-being, flushing, hot flashes, jaw tightness, headache, neck tightness, palpitations, throat tightness, tremor, vomiting, and warm sensations. Rare side effects may include acid indigestion, agitation, allergic reactions, anxiety, blurred vision, bone pain, burning eyes, changes in taste, chest pain, chills, cold hands and feet, confusion, constipation, dehydration, depression, disorientation, difficulty swallowing, dream abnormality, dry eyes, ear pain, eye irritation, eye pain, face swelling, fast or slow heartbeat, gas, hangover feeling, heart attack, heat sensitivity, hives, increased blood pressure, increased urination, increased sensitivity to pain, indigestion, insomnia, irregular heartbeat, irritability, itching, joint pain, lack of coordination, loss of body fluids, memory impairment, menstruation disorder, muscle cramp, muscle pain, muscle spasm, muscle weakness, nasal congestion, nasal dryness, nasal irritation, nervousness, nosebleeds, rash, ringing in the ears, sinus problems, skin peeling, skin swelling, speech difficulties, stiffness, stomach bloating, stroke, sweating, taste and smell abnormalities, tearing eyes, thirst, tongue swelling, throat irritation, throat dryness, throat swelling, upper respiratory infection, urinary frequency, walking abnormalities, wheezing, vertigo, or yawning. Overdose The most common symptoms of an acute overdose are: convulsions, severe somnolence (drowsiness), rapid or irregular heartbeat, and/or breathing difficulty. In case of hallucinations, vomiting, or a change in body temperature, gastric lavage (stomach pumping) and the administration of activated charcoal are recommended. Consult a doctor or visit an emergency room immediately if you experience any of these symptoms while taking Yurelax. Storage Instructions Maxalt and Maxalt may be stored at room temperature. Keep the Maxalt bottle tightly closed. Leave each Maxalt tablet in its pouch. |
